Brief: Everest Medicines Announces That Spero Therapeutics Entered Into Licensing Agreement With Pfizer Inc. For Spr206 In Ex-U.S. And Ex-Asia Territories

Everest Medicines

05/07/2021 11:11

July 5 (Reuters) - Everest Medicines Ltd  1952.HK :
    * EVEREST MEDICINES ANNOUNCES THAT SPERO THERAPEUTICS
ENTERED INTO
LICENSING AGREEMENT WITH PFIZER INC. FOR SPR206 IN EX-U.S. AND
EX-ASIA TERRITORIES
    * EVEREST MEDICINES - UNDER AGREEMENT, SPERO GRANTED PFIZER
RIGHTS
TO DEVELOP, MANUFACTURE, AND COMMERCIALIZE SPR206 IN EX-U.S. AND
EX-ASIA TERRITORIES
    * EVEREST MEDICINES LTD - IN EXCHANGE FOR THESE RIGHTS,
SPERO IS
ELIGIBLE TO RECEIVE UP TO $80 MILLION IN DEVELOPMENT AND SALES
MILESTONES
    * EVEREST MEDICINES -  IN EXCHANGE FOR THESE RIGHTS, SPERO
IS
ELIGIBLE TO RECEIVE HIGH SINGLE DIGIT TO LOW DOUBLE-DIGIT
ROYALTIES ON NET SALES OF SPR206

Source text for Eikon:  ID:nPn9dwSrla 
Further company coverage:  1952.HK 

 ((Reuters.Briefs@thomsonreuters.com;))